ahlam1399
09-23-2015, 06:53 PM
Steep discounts help biotech drug copies gain ground in Europe
LONDON (Reuters) - Cut-price versions of expensive biotech ***** are gaining ground in Europe, following surprisingly steep price discounts offered on the first copy of a complex antibody medicine for rheumatoid arthritis and Crohn's disease.
http://rc.feedsportal.com/r/238386185278/u/49/f/654207/c/35217/s/4a19dd10/sc/21/rc/1/rc.img (http://rc.feedsportal.com/r/238386185278/u/49/f/654207/c/35217/s/4a19dd10/sc/21/rc/1/rc.htm)
http://rc.feedsportal.com/r/238386185278/u/49/f/654207/c/35217/s/4a19dd10/sc/21/rc/2/rc.img (http://rc.feedsportal.com/r/238386185278/u/49/f/654207/c/35217/s/4a19dd10/sc/21/rc/2/rc.htm)
http://rc.feedsportal.com/r/238386185278/u/49/f/654207/c/35217/s/4a19dd10/sc/21/rc/3/rc.img (http://rc.feedsportal.com/r/238386185278/u/49/f/654207/c/35217/s/4a19dd10/sc/21/rc/3/rc.htm)
http://da.feedsportal.com/r/238386185278/u/49/f/654207/c/35217/s/4a19dd10/sc/21/a2.img (http://da.feedsportal.com/r/238386185278/u/49/f/654207/c/35217/s/4a19dd10/sc/21/a2.htm)
http://adchoice.feedsportal.com/r/238386185278/u/49/f/654207/c/35217/s/4a19dd10/sc/21/ach.img (http://adchoice.feedsportal.com/r/238386185278/u/49/f/654207/c/35217/s/4a19dd10/sc/21/ach.htm)http://pi.feedsportal.com/r/238386185278/u/49/f/654207/c/35217/s/4a19dd10/sc/21/a2t.imghttp://pi2.feedsportal.com/r/238386185278/u/49/f/654207/c/35217/s/4a19dd10/sc/21/a2t2.imghttp://i2.wp.com/reuters.us.feedsportal.com/c/35217/f/654207/s/4a19dd10/sc/21/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=R3pnSrq_NjY:Gq3-D5WmtH8:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=R3pnSrq_NjY:Gq3-D5WmtH8:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=R3pnSrq_NjY:Gq3-D5WmtH8:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=R3pnSrq_NjY:Gq3-D5WmtH8:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=R3pnSrq_NjY:Gq3-D5WmtH8:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/R3pnSrq_NjY
LONDON (Reuters) - Cut-price versions of expensive biotech ***** are gaining ground in Europe, following surprisingly steep price discounts offered on the first copy of a complex antibody medicine for rheumatoid arthritis and Crohn's disease.
http://rc.feedsportal.com/r/238386185278/u/49/f/654207/c/35217/s/4a19dd10/sc/21/rc/1/rc.img (http://rc.feedsportal.com/r/238386185278/u/49/f/654207/c/35217/s/4a19dd10/sc/21/rc/1/rc.htm)
http://rc.feedsportal.com/r/238386185278/u/49/f/654207/c/35217/s/4a19dd10/sc/21/rc/2/rc.img (http://rc.feedsportal.com/r/238386185278/u/49/f/654207/c/35217/s/4a19dd10/sc/21/rc/2/rc.htm)
http://rc.feedsportal.com/r/238386185278/u/49/f/654207/c/35217/s/4a19dd10/sc/21/rc/3/rc.img (http://rc.feedsportal.com/r/238386185278/u/49/f/654207/c/35217/s/4a19dd10/sc/21/rc/3/rc.htm)
http://da.feedsportal.com/r/238386185278/u/49/f/654207/c/35217/s/4a19dd10/sc/21/a2.img (http://da.feedsportal.com/r/238386185278/u/49/f/654207/c/35217/s/4a19dd10/sc/21/a2.htm)
http://adchoice.feedsportal.com/r/238386185278/u/49/f/654207/c/35217/s/4a19dd10/sc/21/ach.img (http://adchoice.feedsportal.com/r/238386185278/u/49/f/654207/c/35217/s/4a19dd10/sc/21/ach.htm)http://pi.feedsportal.com/r/238386185278/u/49/f/654207/c/35217/s/4a19dd10/sc/21/a2t.imghttp://pi2.feedsportal.com/r/238386185278/u/49/f/654207/c/35217/s/4a19dd10/sc/21/a2t2.imghttp://i2.wp.com/reuters.us.feedsportal.com/c/35217/f/654207/s/4a19dd10/sc/21/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=R3pnSrq_NjY:Gq3-D5WmtH8:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=R3pnSrq_NjY:Gq3-D5WmtH8:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=R3pnSrq_NjY:Gq3-D5WmtH8:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=R3pnSrq_NjY:Gq3-D5WmtH8:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=R3pnSrq_NjY:Gq3-D5WmtH8:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/R3pnSrq_NjY